Is histopathology informative for further characterization of DOTANOC-proven islet cell lesions in infancy?
Rakesh Kumar
RK
Gupta
Department of Pathology, G. B. Pant Hospital, New Delhi, India.
Ravindra Kumar
RK
Saran
Pinaki Ranjan
PR
Debnath
Rajiv
R
Chadha
D014408:Biomarkers, Tumor / Q000032:analysis; D053379:Chromogranin A / Q000032:analysis; D003937:Diagnosis, Differential; D005260:Female; D006651:Histocytochemistry; D006801:Humans; D007150:Immunohistochemistry; D007231:Infant, Newborn; D007328:Insulin / Q000032:analysis; D007340:Insulinoma / Q000175:diagnosis* / Q000473:pathology*; D008853:Microscopy; D046768:Nesidioblastosis / Q000175:diagnosis* / Q000473:pathology*; D010179:Pancreas / Q000473:pathology*; D010182:Pancreatic Diseases / Q000175:diagnosis* / Q000473:pathology*; D049268:Positron-Emission Tomography; D016708:Synaptophysin / Q000032:analysis
D014408:Biomarkers, Tumor; C506150:CHGA protein, human; D053379:Chromogranin A; D007328:Insulin; C569014:SYP protein, human; D016708:Synaptophysin